OPTIMIZING SCLERODERMA CENTERS OF EXCELLENCE: PERSPECTIVES FROM PATIENTS AND SYSTEMIC SCLEROSIS (SSC) EXPERTS

被引：0

作者：

Jaeger, V. ^{[1
]}

Aubin, A. ^{[2
]}

Baldwin, N. ^{[3
]}

Fligelstone, K. ^{[4
,5
]}

Sims, R. ^{[6
]}

Welling, J. ^{[7
]}

Burrill, R. ^{[8
]}

Connolly, K. ^{[8
]}

Gordon, J. K. ^{[9
]}

Frech, T. ^{[10
]}

Ngcozana, T. ^{[11
]}

Kowalczyk, M. ^{[12
]}

Lammi, M. R. ^{[13
]}

Lasky, J. A. ^{[14
]}

Walker, U. A. ^{[1
]}

Saketkoo, L. A. ^{[14
,15
]}

机构：

[1] Univ Basel, Dept Rheuamtol, Basel, Switzerland

[2] LSU Hlth Sci Ctr, New Orleans, LA USA

[3] Scleroderma Fdn Chicago, Chicago, IL USA

[4] Scleroderma Soc UK, London, England

[5] Royal Free Hosp, Scleroderma Unit, London, England

[6] Scleroderma Australia, Melbourne, Vic, Australia

[7] Org Syst Autoimmune Dis, Utrecht, Netherlands

[8] Scleroderma Fdn, Danvers, MA USA

[9] Hosp Special Surg, New York, NY 10021 USA

[10] Univ Utah, Salt Lake City, UT USA

[11] Royal Free Hosp, London, England

[12] Tulane Univ, New Orleans, LA 70118 USA

[13] LSU Hlth Sci Ctr, Pulm Med, New Orleans, LA USA

[14] UMC Scleroderma & Sarcoidosis Patient Care & Res, Tulane Lung Ctr, New Orleans, LA USA

[15] Tulane Univ, UMC Scleroderma & Sarcoidosis Patient Care & Res, New Orleans, LA 70118 USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷

关键词：

D O I：

10.1136/annrheumdis-2015-eular.2528

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

AB0711

引用

页码：1135 / 1136

页数：2

共 50 条

[1] Optimizing Scleroderma Centers of Excellence: Perspectives from Patients and Scleroderma (SSc) Experts
Jaeger, Veronika K.
Aubin, Andrew
Baldwin, Nancy
Fligelstone, Kim
Sims, Robyn
Welling, Joep
Burrill, Ryan
Connolly, Kerri
Frech, Tracy
Gordon, Jessica K.
Ngcozana, Tanaka
Kowalczyk, Monika
Lammi, Matthew R.
Walker, Ulrich A.
Saketkoo, Lesley Ann
ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1180 - S1181
[2] THE PATHOGENESIS OF SCLERODERMA (SYSTEMIC-SCLEROSIS, SSC)
LEROY, EC
TROJANOWSKA, M
SMITH, EA
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1991, 9 (02) : 173 - 177
[3] Informatics can identify systemic sclerosis (SSc) patients at risk for scleroderma renal crisis
Redd, Doug
Frech, Tracy M.
Murtaugh, Maureen A.
Rhiannon, Julia
Zeng, Qing T.
COMPUTERS IN BIOLOGY AND MEDICINE, 2014, 53 : 203 - 205
[4] GM genes associated with anticentromere antibody in Japanese patients with systemic sclerosis (Scleroderma, SSc).
Pandey, JP
Kameda, H
Kuwana, M
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 904 - 904
[5] Comparison of estimated Glomerular Filtration Rate (eGFR) and actual GFR in patients with systemic sclerosis (scleroderma, SSc)
Schiopu, Elena
Gadebeku, Crystal A.
Rollins, Kristan
Wade, Michael
Seibold, James R.
Phillips, Kristine
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (05) : S75 - S75
[6] Differences in presentation of young and older systemic scleroderma (ssc) patients in Ssc trials.
Weng, Haoling H.
Ranganath, Veena K.
Oh, MyungShin
Park, Grace
Khanna, Dinesh
Clements, Philip J.
Setoodeh, Katy
Seibold, James R.
Furst, Daniel E.
ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S738 - S738
[7] SARCOIDOSIS IN PATIENTS WITH SYSTEMIC-SCLEROSIS (SSC)
COX, D
CONANT, E
NEWMAN, J
JIMENEZ, S
VARGA, J
ARTHRITIS AND RHEUMATISM, 1994, 37 (06): : R39 - R39
[8] Predictors of the scleroderma phenotype in fibroblasts from systemic sclerosis patients
Qi, Q.
Guo, Q.
Tan, G.
Mao, Y.
Tang, H.
Zhou, C.
Zeng, F.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2009, 23 (02) : 160 - 168
[9] Sequencing of the fibrillin-1 gene in Native Americans with scleroderma (systemic sclerosis or SSc).
Tan, FK
Le, JT
Milewicz, D
Amett, FC
ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S103 - S103
[10] HLA Class II associations in systemic sclerosis (SSc) from the scleroderma family registry and DNA repository.
Mayes, MD
Ahn, CW
Arnett, FC
Charles, J
Reveille, JD
ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S582 - S583

← 1 2 3 4 5 →